You are here

  • Home
  • Archive
  • Volume 7, Issue 2
  • Renin–angiotensin–aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis

Article metrics

Article menu
XML
Meta-analysis
Original research
Renin–angiotensin–aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis

 

Online download statistics by month:

Online download statistics by month: November 2020 to March 2024

AbstractFullPdf
Nov 202020682045394
Dec 2020438424155
Jan 2021393358121
Feb 202117015561
Mar 202117616789
Apr 202116314564
May 202114612651
Jun 2021978850
Jul 2021928536
Aug 20211018438
Sep 20211239865
Oct 202112811194
Nov 2021767661
Dec 2021877627
Jan 2022977428
Feb 2022555422
Mar 2022898127
Apr 2022656230
May 2022575021
Jun 2022544616
Jul 2022445421
Aug 2022756710
Sep 2022604625
Oct 2022544919
Nov 2022585222
Dec 2022504928
Jan 2023343114
Feb 2023555120
Mar 2023363626
Apr 2023181615
May 202324198
Jun 202316127
Jul 202323196
Aug 202335288
Sep 2023323210
Oct 2023252010
Nov 2023584810
Dec 2023353413
Jan 2024393818
Feb 2024363415
Mar 20245142149
Total553351821904